MNV
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Analysts Forecast 18% Upside For EKG
Tuesday, May 16, 7:25 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Implied EKG Analyst Target Price: $21
Tuesday, June 20, 6:59 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Commit To Buy Veracyte At $20, Earn 10.5% Annualized Using Options
Tuesday, July 25, 1:37 PM ET, by Market News Video Staff

Investors considering a purchase of Veracyte Inc (VCYT) shares, but tentative about paying the going ...

VCYT Makes Notable Cross Below Critical Moving Average
Monday, August 7, 12:12 PM ET, by Market News Video Staff

In trading on Monday, shares of Veracyte Inc (VCYT) crossed below their 200 day moving ...

How The Parts Add Up: AFSM Headed For $29
Monday, August 21, 8:31 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Commit To Buy Veracyte At $12.50, Earn 16% Annualized Using Options

By Market News Video Staff, Friday, March 22, 11:35 AM ET
Play Video: How To Sell A PUT


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

Investors eyeing a purchase of Veracyte Inc (NASDAQ:VCYT) shares, but cautious about paying the going market price of $21.10/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $12.50 strike, which has a bid at the time of this writing of 50 cents. Collecting that bid as the premium represents a 4% return against the $12.50 commitment, or a 16% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

Selling a put does not give an investor access to VCYT's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $12.50 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Veracyte Inc sees its shares fall 40.8% and the contract is exercised (resulting in a cost basis of $12.00 per share before broker commissions, subtracting the 50 cents from $12.50), the only upside to the put seller is from collecting that premium for the 16% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Veracyte Inc, and highlighting in green where the $12.50 strike is located relative to that history:

The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the June put at the $12.50 strike for the 16% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Veracyte Inc (considering the last 251 trading day closing values as well as today's price of $21.10) to be 50%. For other put options contract ideas at the various different available expirations, visit the VCYT Stock Options page of StockOptionsChannel.com.

In mid-afternoon trading on Friday, the put volume among S&P 500 components was 957,516 contracts, with call volume at 1.18M, for a put:call ratio of 0.81 so far for the day, which is unusually high compared to the long-term median put:call ratio of .65. In other words, there are lots more put buyers out there in options trading so far today than would normally be seen, as compared to call buyers. Find out which 15 call and put options traders are talking about today.


This Article's Word Cloud:   June   Options   Stock   VCYT   Veracyte   YieldBoost   about   among   annualized   benefit   buyers   call   cents   chart   compared   considering   contract   exercised   fillColor   from   going   history   market   month   only   options   other   owning   premium   price   rate   ratio   represents   return   seller   selling   share   shares   strike   than   that   there   this   today   trading   trailing   twelve   upside   which   would
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Chart Zero Stock Market Game Stock Market Definitions
MNV

Commit To Buy Veracyte At $12.50, Earn 16% Annualized Using Options | Market News Video | Copyright © 2008 - 2024, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.

X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.